Onconova Therapeutics (ONTX) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ONTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 4, 2024 | uk.investing.comOnconova and Trawsfynydd merge to form Traws PharmaApril 4, 2024 | finance.yahoo.comTraws Pharma Full Year 2023 Earnings: Beats ExpectationsApril 3, 2024 | msn.comNewtown’s Onconova Therapeutics Secures $14 Million and New CEO in Merger with TrawsfynyddApril 2, 2024 | markets.businessinsider.comOnconova Acquires Trawsfynydd To Form Traws PharmaApril 2, 2024 | globenewswire.comTraws Pharma Announces New Employee Inducement GrantsMarch 12, 2024 | msn.comOnconova to Unveil New Rigosertib Study Results at Cancer Research MeetingMarch 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX) and Biogen (BIIB)March 8, 2024 | finance.yahoo.comOnconova Therapeutics’ Rigosertib Poster Selected for AACR 2024March 8, 2024 | globenewswire.comOnconova Therapeutics' Rigosertib Poster Selected for AACR 2024February 13, 2024 | investing.comOnconova Therapeutics Inc (ONTX)January 23, 2024 | finance.yahoo.comOnconova Therapeutics, Inc. (ONTX)December 21, 2023 | benzinga.comOnconova Therapeutics Stock (NASDAQ:ONTX) Dividends: History, Yield and DatesDecember 12, 2023 | msn.comOnconova stock falls 10% on preclinical data for lymphoma drugDecember 12, 2023 | finance.yahoo.comOnconova Therapeutics’ Narazaciclib ASH Poster Highlights Activity in Treatment Resistant Mantle Cell LymphomaDecember 8, 2023 | finance.yahoo.comOnconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’sNovember 28, 2023 | finance.yahoo.comOnconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity ConferenceNovember 16, 2023 | finance.yahoo.comOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2023 Earnings Call TranscriptNovember 16, 2023 | finanznachrichten.deOnconova Therapeutics, Inc.: Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comOnconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial ResultsNovember 7, 2023 | finance.yahoo.comOnconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023November 2, 2023 | benzinga.comOnconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCLNovember 2, 2023 | finance.yahoo.comOnconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCLOctober 19, 2023 | markets.businessinsider.comPromising Developments in Onconova Therapeutics’ Drug Narazaciclib Bolster Buy Rating: An AnalysisOctober 19, 2023 | finance.yahoo.comPromising Preclinical Narazaciclib Data Presented at MCL MeetingOctober 12, 2023 | marketwatch.comOnconova Therapeutics Shares Rise 12% On Skin Cancer Treatment DataOctober 12, 2023 | finance.yahoo.comEncouraging Rigosertib Data Presented at EADV as Late BreakerSeptember 28, 2023 | finance.yahoo.comOnconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV CongressSeptember 6, 2023 | finance.yahoo.comOnconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 11, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Their Buy Rating for Onconova Therapeutics (ONTX)August 11, 2023 | finance.yahoo.comQ2 2023 Onconova Therapeutics Inc Earnings CallAugust 10, 2023 | finance.yahoo.comOnconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comOnconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023July 17, 2023 | finance.yahoo.comHere's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn SituationJune 14, 2023 | finance.yahoo.comOnconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant LymphomaJune 7, 2023 | msn.comHC Wainwright & Co. Reiterates Onconova Therapeutics (ONTX) Prior RecommendationJune 6, 2023 | markets.businessinsider.comOnconova Therapeutics (ONTX) Receives a Buy from H.C. WainwrightJune 5, 2023 | finance.yahoo.comOnconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual MeetingMay 25, 2023 | finance.yahoo.comOnconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint BlockadeMay 17, 2023 | marketwatch.com8-K: Onconova Therapeutics, Inc.May 16, 2023 | msn.comHC Wainwright & Co. Reiterates Onconova Therapeutics (ONTX) Buy RecommendationMay 16, 2023 | markets.businessinsider.comOnconova Therapeutics (ONTX) Gets a Buy from Noble FinancialMay 16, 2023 | finanznachrichten.deOnconova Therapeutics, Inc.: Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 16, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX), Cara Therapeutics (CARA) and Minerva Neurosciences (NERV)May 16, 2023 | finance.yahoo.comQ1 2023 Onconova Therapeutics Inc Earnings CallMay 15, 2023 | msn.comOnconova Therapeutics: Q1 Earnings InsightsMay 15, 2023 | finance.yahoo.comOnconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue EstimatesMay 15, 2023 | investing.comOnconova Therapeutics (ONTX) Earnings Dates & ReportsMay 15, 2023 | finance.yahoo.comOnconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 12, 2023 | finance.yahoo.comOnconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial CancerMay 11, 2023 | finance.yahoo.comOnconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer Get Onconova Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ONTX Media Mentions By Week ONTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONTX News Sentiment▼0.000.76▲Average Medical News Sentiment ONTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONTX Articles This Week▼00▲ONTX Articles Average Week Get Onconova Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MBRX News TLSA News VTVT News ASMB News ONCY News PYRGF News ANVS News SLS News SPRO News HOOK News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconova Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
